JAMA. 1933;100(23):1859-1861. doi:10.1001/jama.1933.02740230037008.
Text Size: A A A
Published online

In recent years, medical literature has included several reports on the specificity of amidopyrine (pyramidon) in the treatment of measles.

Amidopyrine as a therapeutic agent in measles was first mentioned by Loewenthal1 in 1924. In his report he stated that amidopyrine, when administered at or before the appearance of the rash, will cause (1) reduction of temperature to normal or nearly normal within twelve hours; (2) inhibition of eruption, at times completely, almost always partially; (3) immediate euphoria; (4) clearing up of conjunctivitis, coryza and cough within a day or two.

On these studies Loewenthal concluded that "the drug acts as promptly in measles as quinine does in malaria, or the salicylates in rheumatic fever. A drug which checks the onward march of the symptoms, and particularly the development of the rash, surely has the right to be called a specific drug."

Independent of Loewenthal's observations and discovery of


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.